ArticleBMJ open2024

Pemafibrate for treating MASLD complicated by hypertriglyceridaemia: a multicentre, open-label, randomised controlled trial study protocol.

Michihiro Iwaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.